Zentalis Pharmaceuticals, Inc.
NASDAQ:ZNTL
4.36 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||||||
| Current Assets: | ||||||||||||||||||||
| Cash & Cash Equivalents
| 36.976 | 37.616 | 28.038 | 110.751 | 266.558 | 36.28 | 43.069 | 42.551 | 55.143 | 30.572 | 59.714 | 40.807 | 49.17 | 28.996 | 54.951 | 92.552 | 96.016 | 63.65 | 82.422 | -25.154 |
| Short Term Investments
| 389.409 | 451.368 | 454.881 | 405.886 | 286.428 | 356.239 | 394.302 | 379.175 | 400.078 | 258.797 | 280.173 | 325.984 | 201.73 | 269.385 | 283.554 | 274.884 | 137.175 | 0 | 0 | 50.308 |
| Cash and Short Term Investments
| 426.385 | 488.984 | 482.919 | 516.637 | 552.986 | 392.519 | 437.371 | 421.726 | 455.221 | 289.369 | 339.887 | 366.791 | 250.9 | 298.381 | 338.505 | 367.436 | 233.191 | 63.65 | 82.422 | 25.154 |
| Net Receivables
| 0 | 0 | 0 | 2.955 | 1.789 | 0 | 7.041 | 4.212 | 5.165 | 4.21 | 4.443 | 0.108 | 1.48 | 1.663 | 0.417 | 0.122 | 0.073 | 0.139 | 0.14 | 0 |
| Inventory
| 0 | 0 | 0 | 7.407 | 8.222 | 0 | -7.041 | -4.212 | -5.165 | 0 | 0 | 0.243 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 13.231 | 14.822 | 13.799 | 1.265 | 0.932 | 17.707 | 14.562 | 12.164 | 12.405 | 7.703 | 6.44 | 10.423 | 7.069 | 6.31 | 6.182 | 5.178 | 5.217 | 2.22 | 1.505 | 0 |
| Total Current Assets
| 439.616 | 503.806 | 496.718 | 528.264 | 563.929 | 410.226 | 451.933 | 433.89 | 467.626 | 301.282 | 350.77 | 377.565 | 259.449 | 306.354 | 345.104 | 372.736 | 238.481 | 66.009 | 84.067 | 25.154 |
| Non-Current Assets: | ||||||||||||||||||||
| Property, Plant & Equipment, Net
| 38.811 | 40.405 | 41.735 | 42.577 | 43.234 | 44.355 | 50.078 | 50.673 | 51.523 | 52.124 | 52.839 | 5.391 | 3.446 | 3.409 | 3.619 | 2.396 | 2.571 | 2.795 | 2.836 | 0 |
| Goodwill
| 3.736 | 3.736 | 3.736 | 3.736 | 3.736 | 3.736 | 3.736 | 3.736 | 3.736 | 3.736 | 3.736 | 3.736 | 3.736 | 3.736 | 3.736 | 3.736 | 3.736 | 3.736 | 3.736 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.8 | 8.8 | 8.8 | 8.8 | 8.8 | 8.8 | 8.8 | 0 |
| Goodwill and Intangible Assets
| 3.736 | 3.736 | 3.736 | 3.736 | 3.736 | 3.736 | 3.736 | 3.736 | 3.736 | 3.736 | 3.736 | 3.736 | 12.536 | 12.536 | 12.536 | 12.536 | 12.536 | 12.536 | 12.536 | 0 |
| Long Term Investments
| 2.681 | 2.681 | 2.681 | 2.627 | 2.627 | 18.903 | 21.213 | 28.035 | 30.406 | 35.744 | 37.495 | 39.326 | 3.021 | 3.264 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 10.339 | -2.627 | -2.627 | 0 | 14.147 | 0 | 0 | 0 | 7.04 | 6.042 | -3.021 | -3.264 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 6.836 | 6.851 | 6.818 | 11.138 | 10.545 | 12.122 | -1.797 | 12.859 | 14.565 | 12.791 | 2.627 | 3.021 | 5.51 | 2.79 | 4.296 | 5.565 | 3.629 | 6.289 | 3.218 | -25.154 |
| Total Non-Current Assets
| 52.064 | 53.673 | 65.309 | 57.451 | 57.515 | 79.116 | 87.377 | 95.303 | 100.23 | 104.395 | 103.737 | 57.516 | 24.513 | 21.999 | 20.451 | 20.497 | 18.736 | 21.62 | 18.59 | -25.154 |
| Total Assets
| 491.68 | 557.479 | 562.027 | 585.715 | 621.444 | 489.342 | 539.31 | 529.193 | 567.856 | 405.677 | 454.507 | 435.081 | 283.962 | 328.353 | 365.555 | 393.233 | 257.217 | 87.629 | 102.657 | 0 |
| Liabilities & Equity: | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Account Payables
| 20.44 | 10.502 | 14.926 | 14.264 | 12.305 | 12.818 | 11.247 | 9.82 | 12.041 | 13.163 | 11.59 | 8.046 | 8.273 | 8.337 | 8.661 | 5.437 | 4.217 | 7.019 | 4.289 | 0 |
| Short Term Debt
| 2.709 | 2.739 | 2.623 | 2.425 | 2.335 | 2.247 | 2.162 | 2.207 | 1.733 | 1.269 | 1.453 | 0.862 | 0.804 | 1.099 | 0.902 | 0.871 | 0.81 | 0.81 | 0.781 | 0 |
| Tax Payables
| 0.425 | 0.403 | 0.281 | 0.654 | 0.622 | 0 | 0 | 0.348 | 0.694 | 0.697 | 0.971 | 0.767 | 0.56 | 0.606 | 0.41 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0.425 | 0.403 | 0.281 | -2.425 | -2.335 | -2.247 | -2.162 | 0 | 0 | 0 | 0 | 0.767 | 0.56 | 0.606 | 0.41 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 43.118 | 41.154 | 51.537 | 44.654 | 39.454 | 43.54 | 45.4 | 42.034 | 34.862 | 29.053 | 30.901 | 29.74 | 23.94 | 22.755 | 18.628 | 17.598 | 10.54 | 9.11 | 9.827 | 0 |
| Total Current Liabilities
| 66.692 | 54.798 | 69.367 | 58.918 | 51.759 | 56.358 | 56.647 | 54.061 | 48.636 | 43.485 | 43.944 | 39.415 | 33.577 | 32.797 | 28.601 | 23.906 | 15.567 | 16.939 | 14.897 | 0 |
| Non-Current Liabilities: | ||||||||||||||||||||
| Long Term Debt
| 41.318 | 42.616 | 43.15 | 43.266 | 44.027 | 44.771 | 45.166 | 0.045 | 45.072 | 44.978 | 44.459 | 0 | 0.296 | 0.438 | 1.097 | 1.031 | 1.262 | 1.484 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | -0 | 0 | 0 | 0 | 0 | -0.045 | -45.072 | -44.978 | -44.459 | 0 | -0.296 | -0.438 | -1.097 | -1.031 | -1.262 | -1.484 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 10.339 | 0 | 0 | 0.756 | 0.853 | 1.225 | 1.325 | 1.548 | 1.622 | 1.67 | 2.48 | 2.48 | 2.48 | 2.463 | 2.463 | 2.463 | 2.463 | 0 |
| Other Non-Current Liabilities
| 1.089 | 1.294 | 1.78 | 1.634 | 2.376 | 1.792 | 2.62 | 45.169 | 45.072 | 44.978 | 44.459 | 0 | 0 | 0 | 1.097 | 0 | 0 | 155.934 | 1.7 | 0 |
| Total Non-Current Liabilities
| 42.407 | 43.91 | 55.269 | 44.9 | 46.403 | 47.319 | 48.639 | 46.394 | 46.397 | 46.526 | 46.081 | 1.67 | 2.776 | 2.918 | 3.577 | 3.494 | 3.725 | 159.881 | 4.163 | 0 |
| Total Liabilities
| 109.099 | 98.708 | 124.636 | 103.818 | 98.162 | 103.677 | 105.286 | 100.455 | 95.033 | 90.011 | 90.025 | 41.085 | 36.353 | 35.715 | 32.178 | 27.4 | 19.292 | 176.82 | 19.06 | 0 |
| Equity: | ||||||||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.528 | 0 | 0 | 0 | 24.795 | 0 | 0 | 155.934 | 141.706 | 59.83 |
| Common Stock
| 0.071 | 0.07 | 0.07 | 0.07 | 0.07 | 0.059 | 0.059 | 0.057 | 0.057 | 0.046 | 0.045 | 0.045 | 0.041 | 0.041 | 0.041 | 0.041 | 0.036 | 3.216 | 0.025 | 0 |
| Retained Earnings
| -966.765 | -878.488 | -888.556 | -827.639 | -772.111 | -659.584 | -596.365 | -541.394 | -486.993 | -418.636 | -359.559 | -309.5 | -305.309 | -250.735 | -200.834 | -160.531 | -125.976 | -99.119 | -82.993 | 0 |
| Accumulated Other Comprehensive Income/Loss
| 0.14 | 0.773 | 2.194 | -0.359 | -0.338 | -0.556 | -1.353 | -2.27 | -1.779 | -1.109 | -0.125 | 0.032 | 0.094 | 0.05 | 0.036 | 0.023 | 0.004 | -0.205 | -0.167 | -35.06 |
| Other Total Stockholders Equity
| 1,349.135 | 1,336.416 | 1,323.576 | 1,309.696 | 1,295.52 | 1,045.568 | 1,031.462 | 972.111 | 961.205 | 734.997 | 723.593 | 702.855 | 529.019 | 519.03 | 509.339 | 501.522 | 339.16 | -155.729 | 18.205 | 7.536 |
| Total Shareholders Equity
| 382.581 | 458.771 | 437.284 | 481.768 | 523.141 | 385.487 | 433.803 | 428.504 | 472.49 | 315.298 | 364.482 | 393.432 | 223.845 | 268.386 | 333.377 | 341.055 | 213.224 | -95.903 | 76.776 | 32.306 |
| Total Equity
| 382.581 | 458.771 | 437.391 | 481.897 | 523.282 | 385.665 | 434.024 | 428.738 | 472.823 | 315.666 | 365.01 | 393.996 | 247.609 | 292.638 | 358.172 | 365.833 | 237.925 | -89.191 | 83.597 | 32.306 |
| Total Liabilities & Shareholders Equity
| 491.68 | 557.479 | 562.027 | 585.715 | 621.444 | 489.342 | 539.31 | 529.193 | 567.856 | 405.677 | 454.507 | 435.081 | 283.962 | 328.353 | 365.555 | 393.233 | 257.217 | 87.629 | 102.657 | 32.306 |